Katherine D Crothall

Kathy joined Aspire as its President, CEO, and Chairman of the Board in November 2010. Prior to Aspire, Kathy was a Principal at Liberty Venture Partners, a venture capital firm located in Philadelphia, from 2006 until November 2010. Prior to Liberty, Kathy was Founder, President, and CEO of Animas Corporation (NASDAQ: PUMP), a leading manufacturer of insulin infusion pumps located in West Chester, PA, from its inception to its acquisition by Johnson & Johnson (J&J) Corporation (NYSE: JNJ) in February 2006. Prior to Animas, Kathy was also the Founder, President, and CEO of two other medical device companies; Luxar Corporation (Seattle, WA) was founded in 1988 and was sold to ESC Medical (NASDAQ: ESCMF), and Laakmann Electro-Optics, founded in 1978, was sold to Johnson & Johnson in 1981. Kathy continued running Laakmann Electro-Optics for five years post-acquisition. Kathy received her BS from University of Pennsylvania and her PhD from University of Southern California, both in Electrical Engineering. She holds over 20 patents and is the recipient of several awards including the Ernst & Young Entrepreneur of the Year Award in 2003 and the Greater Philadelphia Raymond Rafferty Entrepreneurial Excellence Award in 2004. Kathy is a director of Adhezion BioMedical and Xanitos, Inc. She is also an overseer of the School of Engineering and Applied Sciences at the University of Pennsylvania.